Commentary on: Randomized Split-Face Study to Assess the Efficacy and Safety of AbobotulinumtoxinA Versus OnabotulinumtoxinA in the Treatment of Melomental Folds (Depressor Anguli Oris).
Clinical Assistant Professor, Director of Continuing Medical Education, University of British Columbia, Department of Dermatology & Skin Science Vancouver, Canada.
Shannon
S
Humphrey
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005149:Facial Expression; D005152:Facial Muscles / Q000187:drug effects*; D005260:Female; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A; C545476:incobotulinumtoxinA